CJC-1295 (No DAC) 5/10 mg

CJC-1295 (No DAC) is a synthetic growth hormone-releasing hormone (GHRH) analog developed for laboratory research involving endocrine physiology, peptide receptor biology, and growth hormone regulation. Unlike the DAC-modified version, CJC-1295 (No DAC) is designed without a Drug Affinity Complex (DAC), resulting in a shorter duration of activity that closely resembles the body’s natural pulsatile growth hormone release patterns.

Its unique pharmacokinetic profile has made CJC-1295 (No DAC) an important research tool for scientists investigating hypothalamic-pituitary signaling, endocrine communication, metabolic physiology, and hormone secretion dynamics. Ongoing laboratory studies continue to examine its role in cellular signaling pathways and growth hormone axis regulation.

Manufactured under rigorous quality standards, Axiom Prime Labs provides high-purity CJC-1295 (No DAC) engineered for exceptional consistency, reliability, and scientific excellence.

---

Scientific Background

CJC-1295 (No DAC) belongs to a class of synthetic peptides designed to mimic the biological activity of endogenous growth hormone-releasing hormone (GHRH). By interacting with GHRH receptors located within the anterior pituitary, researchers investigate its influence on the physiological regulation of endogenous growth hormone secretion.

Unlike CJC-1295 with DAC, which contains a Drug Affinity Complex to extend circulating half-life, the No DAC formulation has a significantly shorter duration of activity. This characteristic makes it particularly valuable for laboratory investigations focused on pulsatile hormone secretion, receptor responsiveness, and physiological endocrine signaling.

Because of these characteristics, CJC-1295 (No DAC) has become a widely utilized research peptide in endocrine biology, metabolic research, and neuroendocrine physiology.

---

Research Highlights

• Synthetic Growth Hormone-Releasing Hormone (GHRH) Analog
• No Drug Affinity Complex (DAC)
• Investigated for Endocrine & Growth Hormone Research
• High-Purity Lyophilized Research Peptide
• Manufactured Under Rigorous Quality Standards
• Batch-Tested for Identity and Purity
• Excellent Batch-to-Batch Consistency
• Laboratory Research Grade

---

Current Areas of Research

Researchers continue to investigate CJC-1295 (No DAC) in studies involving:

• Growth hormone physiology
• Hypothalamic-pituitary axis regulation
• Endocrine signaling pathways
• Pulsatile hormone secretion
• Metabolic regulation
• Cellular communication
• Neuroendocrine physiology
• Exercise physiology
• Healthy aging research
• Peptide receptor biology

---

Laboratory Specifications

Specification	Details
Product Name	CJC-1295 (No DAC)
Available Strength	10 mg
Peptide Class	Synthetic GHRH Analog
Modification	No Drug Affinity Complex (DAC)
Purity	≥98% by HPLC
Appearance	White to Off-White Lyophilized Powder
Solubility	Soluble in Sterile Water for Laboratory Research
Storage	Store refrigerated at 2–8°C. Protect from heat, moisture, and direct light.
Research Grade	Laboratory Research Use Only

---

The Axiom Standard

At Axiom Prime Labs, quality is the cornerstone of every research material we produce. Every peptide is manufactured under carefully controlled production standards and undergoes comprehensive identity and purity verification before release.

Our commitment to precision manufacturing, scientific integrity, and batch-to-batch consistency provides researchers with dependable laboratory materials engineered to support reproducible scientific investigation.

Every product reflects The Axiom Standard—our commitment to uncompromising quality, precision, and scientific excellence.

---

Axiom Prime Labs Research & Regulatory Statement

Research & Regulatory Statement

Axiom Prime Labs is committed to supplying premium laboratory research materials manufactured to rigorous quality standards. Every product is intended exclusively for scientific and laboratory research conducted by qualified professionals within controlled research environments.

Products offered by Axiom Prime Labs are not intended for human consumption, veterinary use, therapeutic applications, or clinical diagnosis. They have not been evaluated by the U.S. Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.

By purchasing or using these materials, researchers acknowledge their responsibility to comply with all applicable laws, regulations, institutional policies, and laboratory safety procedures governing the handling and use of research peptides and laboratory chemicals.